What types of diseases can this technology treat?

It is intended for intractable diseases such as autoimmune disorders, cardiovascular metabolic diseases, neurodegenerative diseases, and cancer.

How does it differ from conventional fibers?

It can increase the pore size to up to 1,000nm, which is over 50 times larger than previous versions, allowing for the selective adsorption of large-molecule pathogenic substances.

AI News NQ Analysis

Toray Develops Porous Fibers that Adsorb Pathogenic Substances of Intractable Diseases

NQ Score 57/100

AI Summary (NQ-processed)

Toray has developed a technology to control the pore size of PMMA porous fibers up to 1,000nm, enabling the selective removal of large-molecule pathogenic substances. This innovation offers a new blood purification treatment option for intractable diseases such as autoimmune disorders and cancer.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What types of diseases can this technology treat?: A: It is intended for intractable diseases such as autoimmune disorders, cardiovascular metabolic diseases, neurodegenerative diseases, and cancer.
Q: How does it differ from conventional fibers?: A: It can increase the pore size to up to 1,000nm, which is over 50 times larger than previous versions, allowing for the selective adsorption of large-molecule pathogenic substances.